PATIENTS' AND HAEMATOLOGISTS' PREFERENCES ON IMMUNE THROMBOCYTOPENIA (ITP) TREATMENT ALTERNATIVES: A CONJOINT ANALYSIS

被引：0
|
作者：
Alvarez, M. T. [1 ]
Pascual-Izquierdo, C. [2 ]
Sanchez-Gonzalez, B. [3 ]
Di Nicolantonio, R. [4 ]
Gostkorzewicz, J. [4 ]
Morros, M. [5 ]
Artes, M. [5 ]
机构：
[1] La Paz Univ Hosp IdiPaz, Madrid, Spain
[2] Hosp Gen Univ Gregorio Maranon, Madrid, Spain
[3] Hosp Mar Parc Salut, Barcelona, Spain
[4] Novartis Spain, Barcelona, Spain
[5] Adelphi Spain, Barcelona, Spain
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY42
引用
收藏
页码：S909 / S909
页数：1
相关论文
共 50 条
  • [41] Assessing Drug Treatment Preferences of Patients with Crohn's Disease A Conjoint Analysis
    Lichtenstein, Gary R.
    Waters, Heidi C.
    Kelly, Jenna
    McDonald, Susan S.
    Zanutto, Elaine L.
    Hendricks, David
    Rahman, Mirza I.
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2010, 3 (02): : 113 - 123
  • [42] Preferences in medications for patients seeking treatment for opioid use disorder: A conjoint analysis
    Muthulingam, Dharushana
    Hassett, Thomas C.
    Madden, Lynn M.
    Bromberg, Daniel J.
    Fraenkel, Liana
    Altice, Frederick L.
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2023, 154
  • [43] Treatment, Platelet Count Pattern and Comorbidities Among Primary Immune Thrombocytopenia (ITP) Patients Seen in Routine Clinical Practice: Data from the United Kingdom Immune Thrombocytopenia (UK ITP) Registry
    Doobaree, Umesh
    Wyatt, Lara
    Nandigam, Raghava
    Newland, Adrian
    Provan, Andrew
    BLOOD, 2017, 130
  • [44] Consistent Efficacy Demonstrated By Avatrombopag in Immune Thrombocytopenia (ITP) Regardless of the Number of Lines of Prior ITP Treatment
    Blinder, Morey
    Vredenburg, Michael
    Tian, Wei
    Jamieson, Brian
    McCrae, Keith R.
    BLOOD, 2020, 136
  • [45] EFFICACY AND SAFETY OF ROMIPLOSTIM IN PATIENTS ≥65 YEARS WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Michel, M.
    Wasser, J.
    Godeau, B.
    Aledort, L.
    Cooper, N.
    Tomiyama, Y.
    Khellaf, M.
    Wang, X.
    Woodard, P.
    HAEMATOLOGICA, 2013, 98 : 196 - 196
  • [46] ROMIPLOSTIM IN SPLENECTOMIZED (SPLNX) AND NONSPLENECTOMIZED (NONSPLNX) PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Cines, D.
    Wasser, J.
    Rodeghiero, F.
    Chong, B.
    Steurer, M.
    Provan, D.
    Lyons, R.
    Garcia Chavez, J.
    Carpenter, N.
    Wang, X.
    Eisen, M.
    HAEMATOLOGICA, 2016, 101 : 194 - 194
  • [47] Romiplostim: A Bridge To Splenectomy In Three Patients With Refractory Immune Thrombocytopenia (ITP)
    Shah, Dhaval
    Rambally, Siayareh
    Mims, Martha
    Udden, Mark M.
    BLOOD, 2013, 122 (21)
  • [48] Effect of steroids on the activation status of platelets in patients with Immune thrombocytopenia (ITP)
    Bhoria, Preeti
    Sharma, Saniya
    Varma, Neelam
    Malhotra, Pankaj
    Varma, Subhash
    Luthra-Guptasarma, Manni
    PLATELETS, 2015, 26 (02) : 119 - 126
  • [49] Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents
    Ghanima, Waleed
    Junker, Peter
    Hasselbalch, Hans Carl
    Boiocchi, Leonardo
    Geyer, Julia T.
    Feng, Xingmin
    Gudbrandsdottir, Sif
    Orazi, Attilio
    Bussel, James B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (02) : 248 - 255
  • [50] Effects of Ramadan Fasting on Patients with Immune Thrombocytopenia (ITP) Receiving Eltrombopag
    Yassin, Mohamed A.
    Alasmar, Aya
    Chandra, Prem
    Ismail, Omer
    Nashwan, Abdulqadir Jeprel
    Sideeg, Deena
    Ghori, Firdous
    Hamad, Anas
    Ghasoub, Rola
    BLOOD, 2020, 136
12345